Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ANRO US Equity

Alto Neuroscience, Inc.Health Care · Pharmaceutical Preparations · CIK 1999480 · FY ends Dec 31
$34.89
+0.76 (+2.23%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 5 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by PERCEPTIVE ADVISORS LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Vestal Point Capital, LPsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Sirenia Capital Management LPsec.gov ↗
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-2013GSchedule 13G filed — ≥5% beneficial owner (passive) · by EcoR1 Capital, LLCsec.gov ↗
2026-07-148-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-138-K 8.01Other eventssec.gov ↗
2026-07-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-13

Every row is a filed document, checked against its EDGAR index.